NCT00827814View on ClinicalTrials.gov

Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction

PHASE4CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG

Dutasteride

Dutasteride 0.5 mg od.

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Samsung Medical Center

OTHER

NCT00827814 - Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction | Biotech Hunter | Biotech Hunter